These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9424089)

  • 21. Role of intramolecular epitope spreading in pemphigus vulgaris.
    Salato VK; Hacker-Foegen MK; Lazarova Z; Fairley JA; Lin MS
    Clin Immunol; 2005 Jul; 116(1):54-64. PubMed ID: 15925832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IgG against extracellular subdomains of desmoglein 3 relates to clinical phenotype of pemphigus vulgaris.
    Müller R; Svoboda V; Wenzel E; Müller HH; Hertl M
    Exp Dermatol; 2008 Jan; 17(1):35-43. PubMed ID: 18095943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA class II restriction of autoreactive T cell responses in pemphigus vulgaris: review of the literature and potential applications for the development of a specific immunotherapy.
    Riechers R; Grötzinger J; Hertl M
    Autoimmunity; 1999; 30(3):183-96. PubMed ID: 10520901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of desmoglein-3 peptides reveals multiple shared T-cell epitopes in HLA DR4- and DR6-associated pemphigus vulgaris.
    Tong JC; Tan TW; Sinha AA; Ranganathan S
    BMC Bioinformatics; 2006 Dec; 7 Suppl 5(Suppl 5):S7. PubMed ID: 17254312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3.
    Tsunoda K; Ota T; Aoki M; Yamada T; Nagai T; Nakagawa T; Koyasu S; Nishikawa T; Amagai M
    J Immunol; 2003 Feb; 170(4):2170-8. PubMed ID: 12574390
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A higher correlation of the antibody activities against the calcium-dependent epitopes of desmoglein 3 quantified by ethylenediaminetetraacetic acid-treated enzyme-linked immunosorbent assay with clinical disease activities of pemphigus vulgaris.
    Kamiya K; Aoyama Y; Shirafuji Y; Hamada T; Morizane S; Fujii K; Iwatsuki K
    J Dermatol Sci; 2013 Jun; 70(3):190-5. PubMed ID: 23602628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Autoreactive B Cell Subpopulations in Peripheral Blood of Autoimmune Patients With Pemphigus Vulgaris.
    Pollmann R; Walter E; Schmidt T; Waschke J; Hertl M; Möbs C; Eming R
    Front Immunol; 2019; 10():1375. PubMed ID: 31258541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
    Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
    J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris.
    Müller R; Svoboda V; Wenzel E; Gebert S; Hunzelmann N; Müller HH; Hertl M
    Exp Dermatol; 2006 Aug; 15(8):606-14. PubMed ID: 16842599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool.
    Lenz P; Amagai M; Volc-Platzer B; Stingl G; Kirnbauer R
    Arch Dermatol; 1999 Feb; 135(2):143-8. PubMed ID: 10052398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
    Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.
    Tsunoda K; Ota T; Suzuki H; Ohyama M; Nagai T; Nishikawa T; Amagai M; Koyasu S
    Eur J Immunol; 2002 Mar; 32(3):627-33. PubMed ID: 11857336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3).
    Kubo A; Amagai M; Hashimoto T; Doi T; Higashiyama M; Hashimoto K; Yoshikawa K
    Br J Dermatol; 1997 Jul; 137(1):109-13. PubMed ID: 9274636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of low avidity desmoglein 3-reactive T cells in pemphigus vulgaris using HLA-DR beta 1*0402 tetramers.
    Veldman C; Eming R; Wolff-Franke S; Sonderstrup G; Kwok WW; Hertl M
    Clin Immunol; 2007 Mar; 122(3):330-7. PubMed ID: 17113829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3.
    Veldman C; Pahl A; Hertl M
    Immunology; 2009 May; 127(1):40-9. PubMed ID: 18800988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A truncated alternative spliced isoform of human desmoglein 1 contains a specific T cell epitope binding to the pemphigus foliaceus-associated HLA class II DRbeta1*0102 molecule.
    Mouquet H; Farci S; Joly P; Maillère B; Leblond J; Drouot L; Leprince J; Tonon MC; Loiseau P; Charron D; Tron F; Gilbert D
    J Immunol; 2006 Nov; 177(9):6517-26. PubMed ID: 17056584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose pemphigus antibodies against linear epitopes of desmoglein 3 (Dsg3) can induce acantholysis and depletion of Dsg3 from keratinocytes.
    Cirillo N; Femiano F; Gombos F; Lanza A
    Immunol Lett; 2009 Feb; 122(2):208-13. PubMed ID: 19200441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pemphigus autoantibodies generated through somatic mutations target the desmoglein-3 cis-interface.
    Di Zenzo G; Di Lullo G; Corti D; Calabresi V; Sinistro A; Vanzetta F; Didona B; Cianchini G; Hertl M; Eming R; Amagai M; Ohyama B; Hashimoto T; Sloostra J; Sallusto F; Zambruno G; Lanzavecchia A
    J Clin Invest; 2012 Oct; 122(10):3781-90. PubMed ID: 22996451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.
    Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M
    Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.